Loading...
Please wait, while we are loading the content...
Similar Documents
Higher integrity health care: evidence-based shared decision making.
| Content Provider | Semantic Scholar |
|---|---|
| Author | Elwyn, Glyn Fisher, Elliott S. |
| Copyright Year | 2014 |
| Abstract | Two recent books1,2 have added to the body of work3–6 describing how the pharmaceutical industry has influenced medical research in its favor. By selective reporting, targeted educational efforts, and incentivizing prescriber behavior, the industry also has a profound impact on the way medicine is practiced. The medical device industry, promoting advances in procedural and diagnostic arenas, has not yet had the spotlight so carefully focused on it, but any future examination is likely to reveal similar influence. Many companies walk a thin line when it comes to providing free equipment and offering training when promoting the use and uptake of novel technologies.7 In both industries, the interests of patients often take second place to marketing. The accounts in Goldacre’s and Gotzsche’s books cast serious doubt on the governance of current healthcare practice. In addition, billions of dollars are invested in direct-to-consumer advertising and the manufacture of consumer interest in healthcare services, either by creating new disease labels, so-called disease mongering,8 or by promoting the use of drugs to address spurious risk predictions. This has become particularly noticeable given the recent promotion of drugs to reduce cholesterol, control blood pressure, and more recently, prevent bone loss, where in many circumstances, there is increasing debate about the appropriate thresholds for pharmaceutical intervention for these conditions.9 Many have spotted the problem. Physicians and patients tend to assume that newer and more technologically advanced care means better care.10 The practice of medicine has also been heavily influenced by efforts to lower diagnostic thresholds, thereby intervening more often, without paying attention to the increasingly small level of benefit, or to the substantial potential harms.11–13 In 2013, the first international conference was held on the theme of overdiagnosis: >300 researchers, clinicians, and policy … |
| File Format | PDF HTM / HTML |
| DOI | 10.1161/CIRCOUTCOMES.114.000688 |
| PubMed reference number | 25271048 |
| Journal | Medline |
| Volume Number | 7 |
| Issue Number | 6 |
| Alternate Webpage(s) | http://circoutcomes.ahajournals.org/content/circcvoq/7/6/975.full.pdf?download=true |
| Alternate Webpage(s) | https://doi.org/10.1161/CIRCOUTCOMES.114.000688 |
| Journal | Circulation. Cardiovascular quality and outcomes |
| Language | English |
| Access Restriction | Open |
| Content Type | Text |
| Resource Type | Article |
